Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 19-27 , January 2008

In vitro binding of [11C]raclopride with ultrahigh specific activity in rat brain determined by homogenate assay and autoradiography

  • Junko Noguchi

      Affiliations

    • Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan
    • SHI Accelerator Service Co. Ltd., 5-9-11 Kitashinagawa, Shinagawa-ku, Tokyo 141-8686, Japan
    • ,
  • Ming-Rong Zhang

      Affiliations

    • Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan
    • ,
  • Kazuhiko Yanamoto

      Affiliations

    • Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan
    • ,
  • Ryuji Nakao

      Affiliations

    • Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan
    • ,
  • Kazutoshi Suzuki

      Affiliations

    • Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 43 206 4039; fax: +81 43 206 3261.

Received 20 July 2007 ,Revised 11 September 2007 ,Accepted 29 September 2007.

References 

  1. Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986;231:258–261
  2. Farde L, Nordstrom AL, Halldin C, Wiesel FA, Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clin Neuropharmacol. 1992;15(Suppl 1 Pt A):468A–469A
  3. Nordstrom AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry. 1993;33:227–235
  4. Rinne JO, Laihinen A, Rinne UK, Nagren K, Bergman J, Ruotsalainen U. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease. Mov Disord. 1993;8:134–138
  5. Kuroda Y, Motohashi N, Ito H, Ito S, Takano A, Nishikawa T, et al. Effects of repetitive transcranial magnetic stimulation on [(11)C]raclopride binding and cognitive function in patients with depression. J Affect Disord. 2006;95(1–3):35–42
  6. Montgomery AJ, Mehta MA, Grasby PM. Is psychological stress in man associated with increased striatal dopamine levels? A [(11)C]raclopride PET study. Synapse. 2006;60:124–131
  7. Lidow MS, Goldman-Rakic PS. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exper Ther. 1997;283:939–946
  8. Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, et al. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med. 2005;46:964–972
  9. Grunder G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, et al. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology. 2006;31:1027–1035
  10. Farde L, Pauli S, Hall H, Eriksson L, Halldin C, Hogberg T, et al. Stereoselective binding of 11C-raclopride in living human brain a search for extrastriatal central D2-dopamine receptor by PET. Psychopharmacology. 1988;94:471–478
  11. Delforge J, Bottlaender M, Loc'h C, Guenther I, Fuseau C, Bendriem B, et al. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab. 1999;19:533–546
  12. Suhara T, Sudo Y, Okauchi T, Maeda J, Kawabe K, Suzuki K, et al. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int J Neuropsychopharmacol. 1999;2:73–82
  13. Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, et al. Amphetamine-induced displacement of [18F]fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology. 2006;31:1016–1026
  14. Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, et al. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci. 2007;27:3998–4003
  15. Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, et al. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology. 1997;133:396–404
  16. Olsson H, Halldin C, Swahn CG, Farde L. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab. 1999;19:1164–1173
  17. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, et al. Reproducibility of [11C]FLB 457 binding in extrastriatal regions. Nucl Med Commun. 2001;22:1215–1221
  18. Slifstein M, Narendran R, Hwang DR, Sudo Y, Talbot PS, Huang Y, et al. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: single bolus and bolus plus constant infusion studies. Synapse. 2004;54:46–63
  19. Asselin MC, Montgomery AJ, Grasby PM, Hume SP. Quantification of PET studies with the very high-affinity dopamine D(2)/D(3) receptor ligand [(11)C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J Cereb Blood Flow Metab. 2007;27:378–392
  20. Liskowsky DR, Potter LT. D-2 dopamine receptors in the frontal cortex of rat and human. Life Sci. 1985;36:1551–1559
  21. Boyson SJ, McGonigle P, Molinoff PB. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986;6:3177–3188
  22. Camus A, Javoy-Agid F, Dubois A, Scatton B. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine. Brain Res. 1986;375:135–149
  23. Stefanini E, Ortu AM, Vernaleone F, Gessa GL. [3H](−)Sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay. Pharmacol Res Commun. 1987;19:777–791
  24. Lidow MS, Goldman-Rakic PS, Rakic P, Innis RB. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Proc Natl Acad Sci U S A. 1989;86:6412–6416
  25. Ishiwata K, Ogi N, Tanaka A, Senda M. Quantitative ex vivo and in vitro receptor autoradiography using 11C-labeled ligands and an imaging plate: a study with a dopamine D2-like receptor ligand [11C]nemonapride. Nucl Med Biol. 1999;26:291–296
  26. Suzuki K, Yamazaki T, Sasaki M, Kubodera A. Application to ultra high specific activity for 11C-labeled compounds. Synthesis of [11C]FLB-457 and [11C]Ro 15-4513. J Label Compd Radiopharm. 1999;42:s129–s131
  27. Suzuki K, Yamazaki T, Sasaki M, Kubodera A. Specific activity of [11C]CO2 in a N2 gas target: effect of irradiation dose, irradiation history, oxygen content and beam energy. Radiochim Acta. 2000;88:211–215
  28. Noguchi J, Suzuki K. Automated synthesis of the ultra high specific activity of [11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol. 2003;30:335–343
  29. Noguchi J, Zhang M-R, Suzuki K. Application of ultra high specific activity [11C]compound to in vitro ARG. J Label Compd Radiopharm. 2003;46:s240
  30. Jewett DM. A simple synthesis of [11C]methyl triflate. Int J Rad Appl Instrum [A]. 1992;43:1383–1385
  31. Funaki Y, Kato M, Iwata R, Sakurai E, Tashiro M, Ido T, et al. Evaluation of the binding characteristics of [5-(11)C-methoxy]donepezil in the rat brain for in vivo visualization of acetylcholinesterase. J Pharmacol Sci. 2003;91:105–112
  32. Nakao R, Ito T, Hayashi K, Suzuki K. Development and validation of an ultra-fast LC method for the quality control of PET radiopharmaceuticals. J Labelled Compd Radiopharm. 2007;50:S508
  33. Kohler C, Hall H, Ogren SO, Gawell L. Specific in vitro binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol. 1985;34:2251–2259
  34. Rakic P, Goldman-Rakic PS, Gallager D. Quantitative autoradiography of major neurotransmitter receptors in the monkey striate and extrastriate cortex. J Neurosci. 1988;8:3670–3690
  35. Wang GJ, Volkow ND, Fowler JS, Wolf AP, MacGregor RR, Shea CE, et al. Comparison of two PET radioligand for imaging extrastriatal dopamine receptors in the human brain. Synapse. 1993;15:246–249
  36. Olsson H, Halldin C, Farde L. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage. 2004;22:794–803

PII: S0969-8051(07)00248-X

doi: 10.1016/j.nucmedbio.2007.09.009

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 19-27 , January 2008

Article Tools

* Image Usage & Resolution